The World Health Organization (WHO) recently released its 2023 Global Tuberculosis (TB) report, highlighting positive strides in the expansion of TB diagnosis and treatment services worldwide. This marks a promising trend in reversing the adverse impacts of COVID-19 disruptions on TB services. Drawing data from 192 countries and regions, the report discloses that in 2022, a significant number of individuals received TB diagnoses, marking the highest recorded figure since WHO commenced global TB monitoring in 1995.

This rise is attributed to notable improvements in access to and provision of healthcare services across many nations. Notably, regions heavily impacted by the pandemic have made substantial recoveries in TB services. The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, expressed optimism about the substantial progress made, highlighting the unique opportunity to bring about the conclusion of the TB story. On a global scale, an estimated significant number of people fell ill with TB in 2022, up from the preceding year. Geographically, in 2022, the majority of people who developed TB were located in regions significantly affected by the pandemic. Although TB-related deaths saw a slight decrease, disruptions due to COVID-19 led to additional TB-related fatalities during the past years. Multidrug-resistant TB (MDR-TB) remains a significant public health concern, with efforts being made to improve treatment accessibility. The report also acknowledges some progress in developing new TB diagnostics, drugs, and vaccines. However, overall investment in these areas remains a limiting factor.